Skip to main content
Antacids Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Germany, Canada, UK, Brazil - Size and Forecast 2024-2028

Antacids Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Germany, Canada, UK, Brazil - Size and Forecast 2024-2028

Published: Jul 2024 144 Pages SKU: IRTNTR72909

Market Overview at a Glance

$692.3 Mn
Market Opportunity
3.27%
CAGR
3.13
YoY growth 2023-2024(%)

Antacids Market Size 2024-2028 

The antacids market size is forecast to increase by USD 692.3 million at a CAGR of 3.27% between 2023 and 2028. The market in the retail pharmacy sector is experiencing significant growth due to the rising prevalence of gastric diseases, such as gastric ulcers, and the increasing demand for over-the-counter (OTC) drugs for the relief of symptoms. The market is driven by the growing population, particularly the elderly, who are more susceptible to these conditions. Additionally, the expanding e-commerce market is providing greater access to antacids, making them more convenient for consumers. However, the prolonged use of antacids can lead to adverse effects, including decreased absorption of essential nutrients and potential kidney damage. To address these concerns, new medical agents are being developed, including alkaline agents such as sodium, aluminum, magnesium, and calcium, which offer effective relief while minimizing side effects. These new drugs aim to meet the evolving needs of consumers and healthcare providers.

What will be the Size of the Market During the Forecast Period?

Antacids Market Size

 Request Free Sample

Market Segmentation

The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD million" for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

  • Type
    • Non-symmetric antacids
    • Symmetric antacids
  • Geography
    • North America
      • Canada
      • US
    • Europe
      • Germany
      • UK
    • Asia
    • Rest of World (ROW)

By Type Insights

The non-symmetric antacids segment is estimated to witness significant growth during the forecast period. Antacids are over-the-counter (OTC) drugs commonly used in retail pharmacies for the relief of heartburn, acid indigestion, and other gastric diseases. Non-systemic antacids, also known as non-absorbed antacids, are a type of antacid that does not get absorbed into the bloodstream. Instead, they remain in the stomach, where they neutralize stomach acid. Non-systemic antacids are available in various forms, including aluminum-containing antacids, calcium-containing antacids, and magnesium-containing antacids. Aluminum-containing antacids consist of aluminum hydroxide, aluminum phosphate, and other aluminum salts. Calcium-containing antacids contain calcium carbonate and tribasic calcium phosphate. Magnesium-containing antacids consist of magnesium carbonate, magnesium citrate, magnesium hydroxide, magnesium oxide, and magnesium phosphate.

In addition, when used alone, non-systemic antacids provide temporary relief from symptoms. However, when taken in combination, they can offer more significant benefits than a single agent. For instance, the combination of aluminum-containing and magnesium-containing antacids can provide longer-lasting relief from symptoms. These antacids are widely used for the treatment of various acid refluxes, gastroesophageal reflux disease (GERD), and peptic ulcers. In conclusion, non-systemic antacids are essential medications for the relief of gastric discomfort and acidity. Their ability to neutralize stomach acid makes them an effective solution for various gastric diseases. When used in combination, they offer more substantial benefits than a single agent. Retail pharmacies remain a primary source for the purchase of these essential medications.

Antacids Market Size

Get a glance at the market share of various segments Request Free Sample

The non-symmetric antacids segment accounted for USD 2.46 billion in 2018 and showed a gradual increase during the forecast period.

Regional Insights

North America is estimated to contribute 43% to the growth of the global market during the forecast period. Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

Antacids Market Share by Geography

For more insights on the market share of various regions Request Free Sample

The market is witnessing significant growth due to the rising prevalence of gastrointestinal disorders, particularly in the geriatric population. Proton pump inhibitors and other over-the-counter digestive products are increasingly being used to manage acidity problems, including oesophageal cancer and Barrett's esophagus. However, the market's expansion is not without challenges. Milk-alkali syndrome and rebound hyperacidity are potential side effects of long-term antacid use, leading to concerns regarding aluminum hydroxide's safety. Moreover, aluminum poisoning, osteomalacia, and hypophosphatemia are risks associated with excessive aluminum intake. In the APAC region, while growth is expected to be the fastest, factors such as low per capita income and a poor distribution network hinder market expansion.

For instance, China and India's per capita income in 2020 was USD10,484 and USD1,928, respectively, compared to USD63,416 and USD40,406 in the US and the UK. Despite these challenges, the market's growth is driven by increasing awareness of treatment options for gastrointestinal disorders and a focus on improving healthcare.

Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

Over-the-counter (OTC) antacids have long been a staple in the US healthcare market, providing relief for millions of individuals suffering from acidity problems. These oral medications, available in both tablet and liquid forms, are designed to neutralize stomach acid and alleviate symptoms of heartburn and indigestion. Gastrointestinal disorders, such as acid reflux, peptic ulcers, and digestive disorders, affect a significant portion of the US population. The prevalence of these conditions increases with age, particularly among the geriatric population. OTC antacids cater to this demographic, offering quick and effective relief for those unable to visit a general practitioner.

In addition, acidity problems can be attributed to various lifestyle factors, including stress, smoking, alcohol consumption, obesity, and certain medications. OTC antacids provide a convenient solution for managing these symptoms, making them an essential part of many households. The market for OTC antacids is diverse, with a range of active ingredients including sodium, calcium, magnesium, and aluminum-based antacids. Commonly used antacids include aluminum hydroxide, which is effective in neutralizing stomach acid, and calcium carbonate, which provides an additional benefit of providing calcium supplementation. The demand for OTC antacids is driven by several factors. The increasing prevalence of gastrointestinal disorders, particularly among the aging population, is a significant growth driver.

Market Driver

Rising geriatric population is the key driver of the market. In the United States, the prevalence of gastrointestinal issues, particularly acidity and heartburn, increases with age. The esophageal sphincter, which prevents stomach acid from flowing back into the esophagus, can weaken over time, leading to acid reflux and heartburn. Additionally, the digestive system's functionality may decline with age, further contributing to these conditions. Gastroesophageal reflux disease (GERD) is another common cause of heartburn, and its prevalence increases with age.

The aging population is a significant factor driving the demand for acid-reducing medications, including antacid products. These medications provide relief from the discomfort and pain associated with acidity and heartburn. Factors such as stress, smoking, and alcohol consumption can exacerbate these conditions and increase the need for antacids. In addition, the pharmaceutical sector continues to innovate, offering various forms of acid-reducing medications, including over-the-counter antacids and injectables, to cater to the diverse needs of consumers.

Market Trends

Growing e-commerce market is the upcoming trend in the market. The market in the United States is witnessing a significant rise in sales through online channels due to the convenience and ease of purchasing over-the-counter (OTC) medications without a prescription. Consumers find it convenient to shop online, as they do not need extensive product knowledge. Retailers have enhanced the online shopping experience by providing better product education and targeted marketing, increasing consumer comfort in buying antacids online. Various organizations have entered this market, contributing to its growth. The strong viability of e-commerce platforms is further driving antacid sales. Sodium antacids, calcium antacids, magnesium antacids, and aluminum antacids are commonly used to alleviate symptoms of heartburn and indigestion.

Furthermore, these antacids are available in both tablet and liquid forms for oral administration. Hospitals, homecare settings, specialty centers, hospital pharmacies, and online pharmacies are major distribution channels for antacids. The market caters to a wide range of consumers, including those suffering from occasional heartburn and indigestion, as well as those with chronic conditions. The market growth is fueled by the increasing prevalence of gastrointestinal disorders and the availability of a diverse range of antacid products to cater to various consumer needs. Online retailers' efforts to improve the shopping experience and the convenience of purchasing antacids from the comfort of one's home have made a significant impact on market growth.

Market Challenge

Adverse effect of prolonged use of antacids is a key challenge affecting the market growth. Antacids are commonly used to alleviate symptoms of heartburn, indigestion, and acid reflux. These medications work by neutralizing excess stomach acid. However, excessive use or high doses of antacids, particularly those containing calcium such as Maalox, Mylanta, Rolaids, and TUMS, can lead to health concerns. Calcium overdose is a potential risk, resulting in side effects like nausea, vomiting, mood swings, kidney stones, gas, belching, and swelling of the feet and ankles. Long-term antacid use can also result in the milk-alkali syndrome, which causes metabolic alkalosis and rebound acidity due to dose dependence. Antacids made with aluminum hydroxide may cause constipation, aluminum intoxication, osteocalcin, and hypophosphatemia.

Furthermore, in contrast, magnesium-containing antacids can lead to diarrhea due to their laxative effect. As obesity rates rise in the US, the demand for antacids has increased. General practitioners and gastroenterologists often prescribe these medications to their patients for symptomatic disorders. With the convenience of e-commerce and online retail channels, antacid consumption has become more accessible. However, it is essential to follow the recommended dosage to avoid potential health risks. Mouth-melting antacids, micro granules, herbal ingredients, liquids, and chewable tablets are available in various forms to cater to diverse consumer preferences. Antacids have become an essential part of many households in the US, providing quick relief from acid reflux and heartburn symptoms.

Exclusive Customer Landscape

The market forecasting report includes the adoption lifecycle of the market, covering from the innovator's stage to the laggard's stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.

Antacids Market Share by Geography

 Customer Landscape

Key Companies & Market Insights

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.

Bayer AG: The company offers antacids that is a naturally made water dissolving formula to cure acidity and heartburn, under the brand name of American Health Packaging.

The market research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:

  • AmerisourceBergen Corp.
  • Advance Pharmaceutical Inc
  • Cardinal Health Inc.
  • GlaxoSmithKline Plc
  • Humco Holding Group Inc.
  • inovapharma.com
  • Johnson and Johnson Services Inc.
  • Neogen Corp.
  • Novartis AG
  • NuCare Laboratories India
  • Pfizer Inc.
  • Pharmaceutical Associates Inc.
  • Sanofi SA
  • Sun Pharmaceutical Industries Ltd.
  • The Procter and Gamble Co.
  • United Natural Foods Inc.
  • WellSpring Pharmaceutical Corp.

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Research Analyst Overview

Antacids are oral medications used to provide quick relief from symptoms of heartburn and indigestion, which include pain, inflammation, and acid reflux. These medications work by neutralizing the stomach acid, reducing the production of gastric acid, or coating the esophagus to protect it from acid damage. Antacids come in various forms, including tablets and liquids, and are available over-the-counter (OTC) at retail pharmacies, hospital pharmacies, online pharmacies, specialty centers, and even in hospitals. The market caters to a wide range of gastrointestinal disorders, such as gastric ulcers, GERD (Gastroesophageal Reflux Disease), acid reflux, constipation, diarrhea, and kidney problems. Antacids are also used to treat symptoms of acidity problems, such as heartburn, indigestion, and inflammation, in the geriatric population and those suffering from oesophageal cancer, Barrett's esophagus, milk-alkali syndrome, and rebound hyperacidity.

Furthermore, the pharmaceutical sector offers various antacid products, including sodium antacids, aluminum antacids, magnesium antacids, and calcium antacids. These medications are used to provide relief from symptoms of acidity problems, which can be caused by stress, smoking, alcohol consumption, obesity, and certain medical conditions. Antacids are available in various forms, such as mouth-melting antacids, micro granules, and herbal ingredients, to cater to diverse consumer preferences. The healthcare infrastructure, including hospitals, healthcare facilities, and general practitioners, also plays a crucial role in the market. Gastroenterologists and other healthcare professionals often prescribe antacids to patients suffering from gastrointestinal issues, such as peptic ulcers and digestive disorders.

In addition, the increasing prevalence of these conditions, along with the growing awareness of the importance of managing acidity problems, is expected to drive the demand for antacid products in the coming years. The market is also witnessing the emergence of new drugs and medical agents, such as proton pump inhibitors and acid reducers (famotidine), which offer dual-action relief for various gastrointestinal disorders. These medications are increasingly being used to treat symptoms of acidity problems, such as heartburn, indigestion, and inflammation, in place of traditional antacids. The growing popularity of e-commerce and online retail channels is also expected to boost the sales of antacids, making them more accessible to consumers.

However, the use of antacids is not without risks. Long-term use of antacids, especially aluminum-containing antacids, can lead to aluminum poisoning, osteomalacia, and hypophosphatemia. Dose-dependent rebound hyperacidity is also a concern with some antacids, making it essential for consumers to follow the recommended dosage and consult their healthcare professionals before using these medications. In conclusion, the market is a significant and growing sector within the pharmaceutical industry, catering to the diverse needs of consumers suffering from various gastrointestinal disorders. The market offers a wide range of antacid products, including tablets, liquids, and various forms of herbal ingredients, to provide quick and effective relief from symptoms of acidity problems. The growing awareness of the importance of managing acidity problems, coupled with the increasing prevalence of gastrointestinal disorders and the growing popularity of e-commerce and online retail channels, is expected to drive the demand for antacids in the coming years.

Market Scope

Report Coverage

Details

Page number

144

Base year

2023

Historic period

2018-2022

Forecast period

2024-2028

Growth momentum & CAGR

Accelerate at a CAGR of 3.27%

Market growth 2024-2028

USD 692.3 million

Market structure

Fragmented

YoY growth 2023-2024(%)

3.13

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 43%

Key countries

US, Germany, Canada, UK, and Brazil

Competitive landscape

Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks

Key companies profiled

Advance Pharmaceutical Inc., AmerisourceBergen Corp., Bayer AG, Cardinal Health Inc., GlaxoSmithKline Plc, Humco Holding Group Inc., inovapharma.com, Johnson and Johnson Services Inc., Neogen Corp., Novartis AG, NuCare Laboratories India, Pfizer Inc., Pharmaceutical Associates Inc., Sanofi SA, Sun Pharmaceutical Industries Ltd., The Procter and Gamble Co., United Natural Foods Inc., and WellSpring Pharmaceutical Corp.

Market dynamics

Parent market analysis, market growth inducers and obstacles, market forecast, fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, market condition analysis for the forecast period

Customization purview

If our market report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request Free Sample

What are the Key Data Covered in this Market Research and Growth Report?

  • CAGR of the market during the forecast period
  • Detailed information on factors that will drive the market growth and forecasting between 2024 and 2028
  • Precise estimation of the size of the market  and its contribution of the market in focus to the parent market
  • Accurate predictions about upcoming market growth and trends and changes in consumer behaviour
  • Growth of the market across North America, Europe, Asia, and Rest of World (ROW)
  • Thorough analysis of the market's competitive landscape and detailed information about companies
  • Comprehensive analysis of factors that will challenge the growth of market companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Executive Summary - Chart on Market Overview
    • Executive Summary - Data Table on Market Overview
    • Executive Summary - Chart on Global Market Characteristics
    • Executive Summary - Chart on Market by Geography
    • Executive Summary - Chart on Market Segmentation by Type
    • Executive Summary - Chart on Incremental Growth
    • Executive Summary - Data Table on Incremental Growth
    • Executive Summary - Chart on Company Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Parent Market
    • Data Table on - Parent Market
  • 2.2 Market characteristics
    • Market characteristics analysis
  • 2.3 Value chain analysis
    • Value Chain Analysis

3 Market Sizing

  • 3.1 Market definition
    • Offerings of companies included in the market definition
  • 3.2 Market segment analysis
    • Market segments
  • 3.3 Market size 2023
    • 3.4 Market outlook: Forecast for 2023-2028
      • Chart on Global - Market size and forecast 2023-2028 ($ million)
      • Data Table on Global - Market size and forecast 2023-2028 ($ million)
      • Chart on Global Market: Year-over-year growth 2023-2028 (%)
      • Data Table on Global Market: Year-over-year growth 2023-2028 (%)

    4 Historic Market Size

    • 4.1 Global Antacids Market 2018 - 2022
      • Historic Market Size - Data Table on Global Antacids Market 2018 - 2022 ($ million)
    • 4.2 Type segment analysis 2018 - 2022
      • Historic Market Size - Type Segment 2018 - 2022 ($ million)
    • 4.3 Geography segment analysis 2018 - 2022
      • Historic Market Size - Geography Segment 2018 - 2022 ($ million)
    • 4.4 Country segment analysis 2018 - 2022
      • Historic Market Size - Country Segment 2018 - 2022 ($ million)

    5 Five Forces Analysis

    • 5.1 Five forces summary
      • Five forces analysis - Comparison between 2023 and 2028
    • 5.2 Bargaining power of buyers
      • Bargaining power of buyers - Impact of key factors 2023 and 2028
    • 5.3 Bargaining power of suppliers
      • Bargaining power of suppliers - Impact of key factors in 2023 and 2028
    • 5.4 Threat of new entrants
      • Threat of new entrants - Impact of key factors in 2023 and 2028
    • 5.5 Threat of substitutes
      • Threat of substitutes - Impact of key factors in 2023 and 2028
    • 5.6 Threat of rivalry
      • Threat of rivalry - Impact of key factors in 2023 and 2028
    • 5.7 Market condition
      • Chart on Market condition - Five forces 2023 and 2028

    6 Market Segmentation by Type

    • 6.1 Market segments
      • Chart on Type - Market share 2023-2028 (%)
      • Data Table on Type - Market share 2023-2028 (%)
    • 6.2 Comparison by Type
      • Chart on Comparison by Type
      • Data Table on Comparison by Type
    • 6.3 Non-symmetric antacids - Market size and forecast 2023-2028
      • Chart on Non-symmetric antacids - Market size and forecast 2023-2028 ($ million)
      • Data Table on Non-symmetric antacids - Market size and forecast 2023-2028 ($ million)
      • Chart on Non-symmetric antacids - Year-over-year growth 2023-2028 (%)
      • Data Table on Non-symmetric antacids - Year-over-year growth 2023-2028 (%)
    • 6.4 Symmetric antacids - Market size and forecast 2023-2028
      • Chart on Symmetric antacids - Market size and forecast 2023-2028 ($ million)
      • Data Table on Symmetric antacids - Market size and forecast 2023-2028 ($ million)
      • Chart on Symmetric antacids - Year-over-year growth 2023-2028 (%)
      • Data Table on Symmetric antacids - Year-over-year growth 2023-2028 (%)
    • 6.5 Market opportunity by Type
      • Market opportunity by Type ($ million)
      • Data Table on Market opportunity by Type ($ million)

    7 Customer Landscape

    • 7.1 Customer landscape overview
      • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    8 Geographic Landscape

    • 8.1 Geographic segmentation
      • Chart on Market share by geography 2023-2028 (%)
      • Data Table on Market share by geography 2023-2028 (%)
    • 8.2 Geographic comparison
      • Chart on Geographic comparison
      • Data Table on Geographic comparison
    • 8.3 North America - Market size and forecast 2023-2028
      • Chart on North America - Market size and forecast 2023-2028 ($ million)
      • Data Table on North America - Market size and forecast 2023-2028 ($ million)
      • Chart on North America - Year-over-year growth 2023-2028 (%)
      • Data Table on North America - Year-over-year growth 2023-2028 (%)
    • 8.4 Europe - Market size and forecast 2023-2028
      • Chart on Europe - Market size and forecast 2023-2028 ($ million)
      • Data Table on Europe - Market size and forecast 2023-2028 ($ million)
      • Chart on Europe - Year-over-year growth 2023-2028 (%)
      • Data Table on Europe - Year-over-year growth 2023-2028 (%)
    • 8.5 Asia - Market size and forecast 2023-2028
      • Chart on Asia - Market size and forecast 2023-2028 ($ million)
      • Data Table on Asia - Market size and forecast 2023-2028 ($ million)
      • Chart on Asia - Year-over-year growth 2023-2028 (%)
      • Data Table on Asia - Year-over-year growth 2023-2028 (%)
    • 8.6 Rest of World (ROW) - Market size and forecast 2023-2028
      • Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
      • Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
      • Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
      • Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
    • 8.7 US - Market size and forecast 2023-2028
      • Chart on US - Market size and forecast 2023-2028 ($ million)
      • Data Table on US - Market size and forecast 2023-2028 ($ million)
      • Chart on US - Year-over-year growth 2023-2028 (%)
      • Data Table on US - Year-over-year growth 2023-2028 (%)
    • 8.8 Germany - Market size and forecast 2023-2028
      • Chart on Germany - Market size and forecast 2023-2028 ($ million)
      • Data Table on Germany - Market size and forecast 2023-2028 ($ million)
      • Chart on Germany - Year-over-year growth 2023-2028 (%)
      • Data Table on Germany - Year-over-year growth 2023-2028 (%)
    • 8.9 Canada - Market size and forecast 2023-2028
      • Chart on Canada - Market size and forecast 2023-2028 ($ million)
      • Data Table on Canada - Market size and forecast 2023-2028 ($ million)
      • Chart on Canada - Year-over-year growth 2023-2028 (%)
      • Data Table on Canada - Year-over-year growth 2023-2028 (%)
    • 8.10 UK - Market size and forecast 2023-2028
      • Chart on UK - Market size and forecast 2023-2028 ($ million)
      • Data Table on UK - Market size and forecast 2023-2028 ($ million)
      • Chart on UK - Year-over-year growth 2023-2028 (%)
      • Data Table on UK - Year-over-year growth 2023-2028 (%)
    • 8.11 Brazil - Market size and forecast 2023-2028
      • Chart on Brazil - Market size and forecast 2023-2028 ($ million)
      • Data Table on Brazil - Market size and forecast 2023-2028 ($ million)
      • Chart on Brazil - Year-over-year growth 2023-2028 (%)
      • Data Table on Brazil - Year-over-year growth 2023-2028 (%)
    • 8.12 Market opportunity by geography
      • Market opportunity by geography ($ million)
      • Data Tables on Market opportunity by geography ($ million)

    9 Drivers, Challenges, and Opportunity/Restraints

    • 9.1 Market drivers
      • 9.2 Market challenges
        • 9.3 Impact of drivers and challenges
          • Impact of drivers and challenges in 2023 and 2028
        • 9.4 Market opportunities/restraints

          10 Competitive Landscape

          • 10.1 Overview
            • 10.2 Competitive Landscape
              • Overview on criticality of inputs and factors of differentiation
            • 10.3 Landscape disruption
              • Overview on factors of disruption
            • 10.4 Industry risks
              • Impact of key risks on business

            11 Competitive Analysis

            • 11.1 Companies profiled
              • Companies covered
            • 11.2 Market positioning of companies
              • Matrix on companies position and classification
            • 11.3 AmerisourceBergen Corp.
              • AmerisourceBergen Corp. - Overview
              • AmerisourceBergen Corp. - Business segments
              • AmerisourceBergen Corp. - Key news
              • AmerisourceBergen Corp. - Key offerings
              • AmerisourceBergen Corp. - Segment focus
            • 11.4 Bayer AG
              • Bayer AG - Overview
              • Bayer AG - Business segments
              • Bayer AG - Key news
              • Bayer AG - Key offerings
              • Bayer AG - Segment focus
            • 11.5 Cardinal Health Inc.
              • Cardinal Health Inc. - Overview
              • Cardinal Health Inc. - Business segments
              • Cardinal Health Inc. - Key news
              • Cardinal Health Inc. - Key offerings
              • Cardinal Health Inc. - Segment focus
            • 11.6 GlaxoSmithKline Plc
              • GlaxoSmithKline Plc - Overview
              • GlaxoSmithKline Plc - Business segments
              • GlaxoSmithKline Plc - Key news
              • GlaxoSmithKline Plc - Key offerings
              • GlaxoSmithKline Plc - Segment focus
            • 11.7 Humco Holding Group Inc.
              • Humco Holding Group Inc. - Overview
              • Humco Holding Group Inc. - Product / Service
              • Humco Holding Group Inc. - Key offerings
            • 11.8 Johnson and Johnson Services Inc.
              • Johnson and Johnson Services Inc. - Overview
              • Johnson and Johnson Services Inc. - Business segments
              • Johnson and Johnson Services Inc. - Key news
              • Johnson and Johnson Services Inc. - Key offerings
              • Johnson and Johnson Services Inc. - Segment focus
            • 11.9 Novartis AG
              • Novartis AG - Overview
              • Novartis AG - Business segments
              • Novartis AG - Key news
              • Novartis AG - Key offerings
              • Novartis AG - Segment focus
            • 11.10 Sanofi SA
              • Sanofi SA - Overview
              • Sanofi SA - Business segments
              • Sanofi SA - Key news
              • Sanofi SA - Key offerings
              • Sanofi SA - Segment focus
            • 11.11 Sun Pharmaceutical Industries Ltd.
              • Sun Pharmaceutical Industries Ltd. - Overview
              • Sun Pharmaceutical Industries Ltd. - Product / Service
              • Sun Pharmaceutical Industries Ltd. - Key news
              • Sun Pharmaceutical Industries Ltd. - Key offerings
            • 11.12 WellSpring Pharmaceutical Corp.
              • WellSpring Pharmaceutical Corp. - Overview
              • WellSpring Pharmaceutical Corp. - Product / Service
              • WellSpring Pharmaceutical Corp. - Key offerings

            12 Appendix

            • 12.1 Scope of the report
              • 12.2 Inclusions and exclusions checklist
                • Inclusions checklist
                • Exclusions checklist
              • 12.3 Currency conversion rates for US$
                • Currency conversion rates for US$
              • 12.4 Research methodology
                • Research methodology
              • 12.5 Data procurement
                • Information sources
              • 12.6 Data validation
                • Data validation
              • 12.7 Validation techniques employed for market sizing
                • Validation techniques employed for market sizing
              • 12.8 Data synthesis
                • Data synthesis
              • 12.9 360 degree market analysis
                • 360 degree market analysis
              • 12.10 List of abbreviations
                • List of abbreviations

              Research Methodology

              Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

              INFORMATION SOURCES

              Primary sources

              • Manufacturers and suppliers
              • Channel partners
              • Industry experts
              • Strategic decision makers

              Secondary sources

              • Industry journals and periodicals
              • Government data
              • Financial reports of key industry players
              • Historical data
              • Press releases

              DATA ANALYSIS

              Data Synthesis

              • Collation of data
              • Estimation of key figures
              • Analysis of derived insights

              Data Validation

              • Triangulation with data models
              • Reference against proprietary databases
              • Corroboration with industry experts

              REPORT WRITING

              Qualitative

              • Market drivers
              • Market challenges
              • Market trends
              • Five forces analysis

              Quantitative

              • Market size and forecast
              • Market segmentation
              • Geographical insights
              • Competitive landscape

              Interested in this report?

              Get your sample now to see our research methodology and insights!

              Download Now

              Frequently Asked Questions

              Antacids market growth will increase by $ 692.3 mn during 2024-2028 .

              The Antacids market is expected to grow at a CAGR of 3.27% during 2024-2028 .

              Antacids market is segmented by Type( Non-symmetric antacids, Symmetric antacids)

              Advance Pharmaceutical Inc., AmerisourceBergen Corp., Bayer AG, Cardinal Health Inc., GlaxoSmithKline Plc, Humco Holding Group Inc., inovapharma.com, Johnson and Johnson Services Inc., Neogen Corp., Novartis AG, NuCare Laboratories India, Pfizer Inc., Pharmaceutical Associates Inc., Sanofi SA, Sun Pharmaceutical Industries Ltd., The Procter and Gamble Co., United Natural Foods Inc., WellSpring Pharmaceutical Corp. are a few of the key vendors in the Antacids market.

              North America will register the highest growth rate of 43% among the other regions. Therefore, the Antacids market in North America is expected to garner significant business opportunities for the vendors during the forecast period.

              US, Germany, Canada, UK, Brazil

              • Rising geriatric populationWith growing age is the driving factor this market.
              • the occurrence of acidity and heartburn increases. There is a valve at the lower end of the esophagus that is designed to keep acid in the stomach. With age is the driving factor this market.
              • this valve or sphincter in the lower esophagus tends to relax is the driving factor this market.
              • which allows acid to reflux or flow backward is the driving factor this market.
              • causing heartburn. Also is the driving factor this market.
              • the digestive system tends to slow down with increasing age is the driving factor this market.
              • which also leads to acidity. Heartburn can also be caused by GERD. Age is directly related to the increase in various disorders is the driving factor this market.
              • including GERD. Thus is the driving factor this market.
              • the growing aging population is a major driving factor for the global antacids market. Further is the driving factor this market.
              • advances in healthcare and advanced treatment options for various diseases have increased the average life expectancy of people. For instance is the driving factor this market.
              • as per the US census bureau is the driving factor this market.
              • in 2015 is the driving factor this market.
              • people aged 65 years and above were approximately 617 million is the driving factor this market.
              • and the number is expected to reach 1 is the driving factor this market.
              • 566 million by 2050. As per data collected by the World Bank and the NIH is the driving factor this market.
              • the percentage of the aging population is expected to grow from 8.48% in 2016 to approximately 17% by 2050. Thus is the driving factor this market.
              • the demand for antacids is expected to increase with the rising aging population is the driving factor this market.
              • thereby driving the market growth. is the driving factor this market.

              The Antacids market vendors should focus on grabbing business opportunities from the Non-symmetric antacids segment as it accounted for the largest market share in the base year.